28,188 Shares in Grail, Inc. (NASDAQ:GRAL) Purchased by Orion Portfolio Solutions LLC

Orion Portfolio Solutions LLC purchased a new position in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 28,188 shares of the company's stock, valued at approximately $503,000. Orion Portfolio Solutions LLC owned about 0.08% of Grail as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently modified their holdings of the stock. Douglas Lane & Associates LLC acquired a new stake in Grail during the 4th quarter valued at approximately $3,034,000. A. D. Beadell Investment Counsel Inc. acquired a new position in Grail during the fourth quarter valued at $430,000. FNY Investment Advisers LLC purchased a new stake in Grail in the fourth quarter valued at $26,000. 180 Wealth Advisors LLC acquired a new stake in Grail during the 4th quarter worth about $1,681,000. Finally, B & T Capital Management DBA Alpha Capital Management acquired a new stake in Grail during the 4th quarter worth about $387,000.

Grail Stock Performance

NASDAQ GRAL traded up $0.51 during mid-day trading on Friday, reaching $23.26. 1,024,682 shares of the stock were exchanged, compared to its average volume of 1,226,001. Grail, Inc. has a 1 year low of $12.33 and a 1 year high of $63.99. The business's 50 day moving average is $33.52 and its 200-day moving average is $23.20.

Grail (NASDAQ:GRAL - Get Free Report) last issued its quarterly earnings data on Thursday, February 20th. The company reported ($1.86) EPS for the quarter, beating the consensus estimate of ($4.41) by $2.55. The business had revenue of $38.25 million during the quarter, compared to analyst estimates of $35.33 million. On average, research analysts predict that Grail, Inc. will post -15.15 earnings per share for the current year.

Remove Ads

Insider Buying and Selling

In other Grail news, President Joshua J. Ofman sold 2,109 shares of the firm's stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $31.20, for a total value of $65,800.80. Following the transaction, the president now directly owns 559,673 shares of the company's stock, valued at $17,461,797.60. This trade represents a 0.38 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Aaron Freidin sold 1,816 shares of the stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $31.20, for a total value of $56,659.20. Following the completion of the sale, the chief financial officer now directly owns 335,170 shares of the company's stock, valued at approximately $10,457,304. This represents a 0.54 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 11,550 shares of company stock valued at $360,436.

Analysts Set New Price Targets

Separately, Morgan Stanley upped their target price on Grail from $16.00 to $20.00 and gave the stock an "equal weight" rating in a research note on Tuesday, March 18th.

About Grail

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.